Selective inhibition of brain endothelial Rho-kinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin

• Be’eri Niego ,

  Contributed equally to this work with: Be’eri Niego, Natasha Lee

  * E-mail: beeri.niego@monash.edu

  ¶‡ BN and RLM are joint senior authors on this work

  Affiliation Molecular Neurotrauma and Haemostasis, Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia

  http://orcid.org/0000-0001-6714-9131

  ⨯
• Natasha Lee ,

  Contributed equally to this work with: Be’eri Niego, Natasha Lee

  Affiliation Molecular Neurotrauma and Haemostasis, Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia

  ⨯
• Pia Larsson,

  Affiliation Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

  ⨯
• T. Michael De Silva,

  Affiliation Department of Physiology, Anatomy and Microbiology, School of Life Sciences, La Trobe University, Melbourne, Victoria, Australia

  ⨯
• Amanda E-Ling Au,

  Current address: Cancer and Haematology Division, The Walter and Eliza Hall Institute, Victoria, Australia and the Department of Medical Biology, The University of Melbourne, Victoria, Australia

  Affiliation Molecular Neurotrauma and Haemostasis, Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia

  ⨯
• Fiona McCutcheon,

  Affiliation Molecular Neurotrauma and Haemostasis, Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia

  ⨯
• Robert L. Medcalf

  ¶‡ BN and RLM are joint senior authors on this work

  Affiliation Molecular Neurotrauma and Haemostasis, Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia

  ⨯